The New York Times - Business:
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.
This post first appeared in The New York Times - Business. Read the original article.
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
